Background: The present study aimed to explore the association of long non‐coding RNA nuclear‐enriched abundant transcript 1 (lnc‐NEAT1) with inflammation, disease activity, treatment outcome, and its targets (microRNA [miR]‐21 and miR‐125a) in patients with rheumatoid arthritis (RA).Methods: Peripheral blood mononuclear cells were sampled from 130 RA patients at baseline, week (W) 6, and W12, as well as from 60 healthy controls (HCs) after enrollment. Meanwhile, the expressions of lnc‐NEAT1, miR‐21, and miR‐125a were detected by reverse transcription‐quantitative polymerase chain reaction.Results: lnc‐NEAT1 was elevated, but miR‐21 and miR‐125a were declined in RA patients compared with HCs (all p < 0.001); meanwhile, lnc‐NEAT1 was negatively correlated with miR‐21 and miR‐125a (both p < 0.05) in RA patients. Besides, elevated lnc‐NEAT1 but declined miR‐21 and miR‐125a were correlated with erythrocyte sedimentation rate (ESR) and C‐reactive protein and the 28‐joint Disease Activity‐ESR score (all p < 0.05) in RA patients. Moreover, lnc‐NEAT1 was declined from baseline to W12 in RA patients (p < 0.001). Additionally, lnc‐NEAT1 at W12 was declined in response patients compared with non‐response patients (p = 0.006), and also decreased in remission patients compared with non‐remission patients (p < 0.001).Conclusion: lnc‐NEAT1 and its targets (miR‐21 and miR‐125a) correlate with RA risk and disease activity, and declined lnc‐NEAT1 associates with better treatment outcome to some extent in RA patients, suggesting that lnc‐NEAT1 might be a potential biomarker to monitor disease activity and treatment outcome in RA.
Spinal cord injury (SCI) is a devastating neurological disease in which astrocytes play a central role. Understanding the relationship between different subtypes of astrocytes and neuron subtypes during the progression of SCI is critical to understanding the disease. In this study, single-cell RNA sequencing (scRNA-seq) was used to analyze the transcriptome data of acute, subacute and intermediate stages of SCI in mice as well as normal tissues. Different subtypes of astrocytes and neuronal cells were identified and their dynamic changes and functionalities during the development of SCI. An intriguing discovery was the identification of a specific subtype of astrocytes characterized by unique expression of Gap43, Vim, Aldoc, and Mt1. This subtype of cells shows similarities in gene expression with neurons and potentially transitioned into neurons during the course of SCI. Furthermore, we have uncovered the important role of the glycolytic pathway in this cellular transformation process. Furthermore, through cellular interaction analysis, we validated pathways (mdk-ptprz1,ptn-ptprz1,ptn-sdc3) associated with the potential conversion of these specific cell subsets into neurons. Finally, these cells were observed by fluorescence microscopy and critical gene expressions were validated by Western blot. The results of this study not only deepen our understanding of the mechanisms underlying SCI, but also provide new insights and opportunities for the development of novel therapeutic strategies and interventions.